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lmmunocontraception in White-Tailed Deer 
John W.Turner, Jr., Jay F. Kirkpatrick, and Irwin K. M. L iu  
Abstract: lmmunocontraception may have management 
application for white-tailed deer populations in parks and 
preserves. where hunting 1s illegal or impractical. This study 
examines physiological aspects of immunocontraception 
with porcine zonae pellucidae in 53 fertile white-tailed does. 
In separate studies, we employed protocols of three and two 
porcine zona pellucida (PZP) injections as well as two 
different protocols using one injection. Each one-injection 
vaccination consisted of one dose of porcine zonae 
pellucidae as in other protocols plus a second controlled- 
release dose of the material delivered via an osmotic 
minipump implant or injected, biodegradable polymer 
micros~heres. We monitored fawn Droduction for 1 to 3 vears 
injections. PZP-treated does showing >50 percent of 
maximal antibody titers at the onset of a breeding season 
did not produce fawns: those showing <33 percent of 
maximal titers did. These data demonstrate in white-tailed 
does that (1) multiple-injection PZP vaccination can produce 
complete contraception for at least one breeding season, 
(2) the contraceptive effect is reversible within 2 years in 
most does, (3) an elevated anti-PZP antibody titer occurs 
after PZP vaccination, and (4) multiple-injection PZP 
vaccination produces a sustained antibody response 
through at least one breeding season. 
In separate field studies of wild, free-roaming deer in 
three locations. we successfullv lured does to within dartino 
n a i obes ano measurea ser-m PZP ant ooay r rers ai 
- 
range -s ng oat slat ons ~n two locar ons we arrempred 
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does and in 2 control does. All three-injectibn PZP does percent of does. In the one iocation for which we have data 
were given a single PZP booster inoculation after 1 year. on fawn production, the fawning incidence was 0110, 619, 
None of the two- or three-injection does and none of the and 819 for two-and one-injection porcine zonae pellucidae 
one-injection does with a minipump produced fawns the first and untreated controls, respectively. In the same location, 
year after treatment, whereas two of seven does given a we monitored seasonal aspects of activity, behavior, and 
sinole iniection with controlled-release miCr0~Dhere~ ohvstcal condition. We also determined that there is a aood 
pr&uced fawns. In 49 control-doe breeding seasons, the boiential for remote assessment of pregnancy in does using 
D00led incidence of fawn ~roduction was 93.8 ~ercent. measurement of ~reanancv-specific elevations of steroid 
kegarding reversibility of infertility, the incidence of fawn metabolites in fecal samples. 
Droduction was 75 Dercent within 2 vears after treatment 
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Introduction 
The purpose of this paper is to present studies per- 
formed by our research team addressing immuno- 
contraception in white-tailed deer (Odocoileus 
virginianus). Our team participated in the 1987 and 
1990 "Contraception in Wildlife" conferences in 
Philadelphia (U.S.A.) and Melbourne (Australia). At 
the 1987 conference, there were no papers address- 
ing immunocontraception; our own work in this area 
was embryonic (Turner and Kirkpatrick 1991). At the 
1993 conference in Denver, CO, there were 16 papers 
on immunocontraception! Since the original studies of 
immunocontraception in feral horses, we have treated 
45 mammalian species with the same porcine zona 
pellucida (PZP) antifertility vaccine. To date, these 
treatments included 157 individuals across 28 species 
of captive, exotic ungulates, with 87.7-percent inhibi- 
tion of fertility in 68 outcomes; and 172 free-roaming 
equids, with 92.5-percent inhibition of fertility in 133 
outcomes. These numbers provide strong encourage- 
ment for the exploration of PZP vaccine use for 
contraception in wildlife. 
The first study of immunocontraception in wildlife 
was in free-roaming feral horses (Kirkpatrick et al. 
1990a). We used PZP vaccine, delivered remotely by 
dart, to produce greater than 95-percent infertility. The 
effects were reversible after 1 year, did not affect 
pregnancies in progress, and did not produce behav- 
ioral side effects (Liu et al. 1989, Kirkpatrick et al. 
1990a and 1991 a). Based on this success using PZP 
vaccine to inhibit fertility in feral horses, we began a 
series of studies to evaluate the potential for PZP 
immunocontraception in white-tailed deer. 
The PZP vaccine appears to act by inhibiting 
fertilization (Sacco et al. 1984). In mammals, the egg 
is surrounded by a noncellular membrane named zona 
pellucida (ZP). The ZP is made up of three glycopro- 
teins; one of these, ZP3, is the sperm receptor 
(Florman and Wassarman 1985). Injection of raw 
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porcine ZP protein plus adjuvant (to enhance the 
immune response) into other species causes the 
female to raise antibodies against the sperm receptor 
on the ovum. It is hypothesized that the antibodies 
bind receptors which prevent sperm binding and, 
hence, fertilization. 
Let us now turn to white-tailed deer. In times 
past, white-tailed deer populations lived unrestricted in 
their habitat, regulated by predation, resource limita- 
tions, and human hunting. With increasing human 
settlement and urbanization, predators have been 
eliminated, and many deer populations and their 
habitat have become islands surrounded by human 
communities. While hunting has been the standard 
approach to controlling North American deer popula- 
tions, it is illegal or impractical in many parks and 
preserves. Furthermore, current management prac- 
tices in these places have not limited populations. 
We have undertaken studies of immunocontra- 
ception in white-tailed deer in hope of developing an 
alternative tool for management of unhuntable popula- 
tions (Kirkpatrick and Turner 1993). We will present 
data from our several studies of captive, unrestrained 
deer and from three ongoing studies of wild, free- 
roaming deer. Major issues which must be addressed 
in considering the potential for PZP vaccine in deer 
contraception essentially comprise the list of require- 
ments for a management-useful contraceptive vaccine 
for deer: ( I )  accessibility to the deer, (2) reliable 
treatment-delivery technology, (3) high efficacy of 
treatment, (4) appropriate duration of treatment effect, 
(5) reversibility of treatment effect, (6) safety of 
treatment to deer and environment, (7) safety of 
. . 
treatment to deer consumer, (8) cost effectiveness of 
treatment, and (9) public acceptance of method and 
treatment. 
In our studies, we have attempted to bring 
together the most important elements of successful 
wildlife contraception: scientifically sound basic 
research and successful application to wild animals in 
the field. This union has included collaborations with 
the Smithsonian Institution's Conservation and Research 
Center (Front Royal, VA) on deer behavior and social 
dynamics; Canada's Pt. Pelee National Park and the 
Ontario Ministry of Natural Resources on access to 
wild deer; Fire Island National Seashore, NY, on 
treatment in the field; and The Humane Society of the 
United States (Washington, DC) on education regard- 
ing urban deer issues. 
Studies in Captive Deer 
Materials and Methods 
General-We examined the effects of a PZP vaccine 
on fertility and plasma antibody titers in studies 
consisting of four experiments testing various proto- 
cols of PZP contraceptive vaccine, each with its own 
controls. Assessment of contraceptive effectiveness 
and reversibility was determined by comparison of 
fawn counts in PZP-treated and control does. Serum 
anti-PZP antibody titers were measured by specific 
enzyme-linked irnmunosorbent assay (ELISA). 
The PZP vaccine, an emulsion of porcine zonae 
pellucidae and adjuvant, was prepared from porcine 
ovaries as described (Liu et al. 1989). It was stored at 
2 0  "C until used in the field. An emulsion of 0.5 cm3 
vaccine (equivalent to approximately 5,000 zonae or 
64.3 pg of protein) in phosphate buffer and 0.5 cm3 of 
Freund's Complete Adjuvant (FCA) was prepared and 
injected remotely (Turner et al. 1992). All inoculations 
subsequent to the first one contained Freund's Incom- 
plete Adjuvant (FIA) in place of FCA. In a previous 
study, the use of incomplete adjuvant in subsequent 
injections produced effective contraception with no 
visible signs of abscess at the injection site (Turner et 
al. 1992). 
~~ ~~ 
The studies were conducted at a private, U.S. 
Department of Agriculture-approved deer facility in 
west-central Ohio (lat. 41" N., long. 84" W.). We used 
53 does ranging in age from 2 to 7 years and in mass 
from 47 to 65 kg. All does had fawned previously. 
They were maintained in two adjoining 0.5-ha, grass- 
covered enclosures with a 3-m chain-link fence. The 
west end of the enclosures was a solid wooden wall 
with an overhang to provide the deer shelter from cold, 
wind, and precipitation. They were fed alfalfa, corn, 
oats, and commercial food pellets (Purina Lamb 
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Conditioner@, Purina Corp., St. Louis, MO). Food and 
water were provided ad libitum. We weighed the does 
and noted their condition when the study began. 
Health and condition of each doe were subjectively 
assessed monthly during the study in terms of vigor, 
demeanor, and physical appearance. Each doe was 
eartagged to facilitate remote identification and 
randomly assigned to a PZP or control group. 
Effects of PZP Vaccine on Fawn Production-For 
each of four experiments, does were vaccinated prior 
to the breeding season, placed with a fertile buck, 
observed for breeding, and observed for fawn produc- 
tion the following spring and summer. Details of these 
activities are presented below. 
Antifertility effectiveness in each experiment was 
determined by comparing fawn production in PZP- 
treated and control does. The PZP vaccine was given 
as two or three injections, 3 weeks apart, or as a 
single injection combined with a 4-week controlled- 
release delivery of porcine zonae pellucidae. A three- 
injection experiment (begun 1989), a two-injection 
experiment (begun 1990), and two one-injection 
experiments (begun 1991 and 1992) were performed 
separately, with respective controls. Untreated 
controls or a combination of does that received sham 
injections (saline and adjuvant) and untreated controls 
were used in each experiment. 
Each year, injections were begun in October. In 
November or early December (3-4 weeks after the 
end of PZP exposure), PZP-treated and control does 
were placed together in groups of no more than 18. A 
single breeder buck was placed with each group. The 
bucks were healthy 3-year-olds that had previously 
sired fawns. We observed breeding within 3 days 
after placing the buck and does together, and the male 
was permitted to remain with the does thereafter. 
Although details of estrus and breeding behavior 
were not recorded, increased activity and restlessness 
of a given doe accompanied by increased attention to 
the doe by the buck, indicated the onset of estrus. A 
breeding was considered to have occurred when the 
buck mounted a receptive doe and, after 7-15 sec- 
onds, the doe and buck separated vigorously (Halls 
1984). Brief mountings ( 3 4  seconds) were not 
considered a successful breeding. During the breed- 
ing season, observations were usually made daily for 
15-30 minutes during feed replenishment, around 
6 A.M. and 5 P. M. 
After the breeding season, deer were observed 
for health and physical condition as described previ- 
ously. Fawning was usually complete by midJune. 
Different incidences of fawning among groups in a 
given experiment were tested for significance using 
binomial probability distribution (Zar 1984). 
In the three-injection experiment treated does 
(n=5) received three separate PZP treatments, three 
weeks apart, beginning October 1989. Control does 
(n=6) were untreated. In October 1990, the above 
PZP-treated does were given a booster inoculation 
(porcine zonae pellucidae + FIA), and the above 
control does were given a sham (saline + FIA) booster 
(n=4) or remained untreated (n=2). In order to deter- 
mine reversibility of treatment effect, the above control 
and previously treated (1989; 1990 booster) does 
received no treatment in October 1991 but were bred 
as usual during November-December 1991. 
In the two-injection experiment, does (n=8) 
received two injections, 3 weeks apart in November 
1990. Control does (n=8) were given salineiadjuvant 
(n=4) or were untreated (n=4). The 16 does in the 
experiment were divided into 2 groups (4 receiving 
porcine zonae pellucidae, 2 receiving sham injections, 
and 2 left untreated in each group). Each group was 
placed in a separate pasture with a buck of proven 
fertility. Fawns were counted in the summer of 1991. 
In order to determine reversibility of treatment effect, 
the remaining PZP-treated and control does were bred 
without further treatment in November 1991 and 
November 1992, and fawns were counted in the 
summers of 1992 and 1993, respectively. 
In the first single-injection, controlled-release 
experiment, six does were given one injection of 
porcine zonae pellucidae (65 kg) and FCA, and on the 
same day an osmotic minipump containing 65 pg of 
porcine zonae pellucidae was implanted subcutane- 
ously in the neck of three of these does. The pump 
was designed to release PZP antigen continuously for 
4 weeks at an approximate rate of 2.5 pgiday. The 
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three other does that received just the single PZP 
injection sewed as "active" controls: two of these 
does were implanted with a pump containing saline 
buffer, and one of these does was not implanted. 
Another six does served as untreated controls. Does 
were bred, and fawns were counted as described 
previously. 
In the second single-injection, controlled-release 
experiment, seven does were each given one injection 
containing 130 pg of porcine zonae pellucidae emulsi- 
fied in FCA. The pellucidae in the injection were 
present in one of two forms: 65 pg unsequestered or 
65 pg sequestered in 10- to 50-p microspheres of 
bioerodable lactide and glycolide polymers in a 1 :1 
ratio. The polymer microspheres were prepared by E. 
Schmitt, R. Linhardt, and D. Flanagan at the University 
of Iowa using a coacervation method described by 
Wang et al. (1991a). Release rates were projected to 
be continuous over approximately 4 weeks, with 
greater release in weeks 1 and 4 (Wang et al. 1990 
and 1991 a). Seven does served as untreated con- 
trols. Does were bred, and fawns were counted as 
previously described. 
Effects of Porcine Zonae Pellucidae on Antibody 
Titers-Anti-PZP antibody titers were measured in 
serum obtained from randomly selected does in each 
of the above experiments. Blood collection was 
scheduled to provide antibody titer data for pre- 
vaccination, peak titer period, and after fawns were 
produced. Except for prevaccination, the timing of 
blood collections was partly dictated by accessibility to 
deer and availability of assistance for their handling. 
In total, 15 PZP-treated and two control does were 
sampled. Does were tranquilized with xylazine 
(1.5 mglkg) delivered by darting. The tranquilizer 
induction time was 8-12 minutes. Samples (10 mL) 
were taken by jugular venipuncture and allowed to clot 
for 1 hour at approximately 30 "C. Serum obtained 
from these samples was frozen at -20 "C until assayed 
for anti-PZP antibody titers. These titers were deter- 
mined using an ELlSA based on the method described 
by Voller et al. (1986), with the modifications reported 
previously for horses (Liu et al. 1989) and additional 
modifications for deer. The assay is described below. 
Fifty pL of 5 pg/mL zona antigen solution in 
0.1 M glycine buffer (pH 9.5) were placed in each well 
of a flat-bottom ELlSA microplate (Cat. #MS-3496, E & 
F Scientific Products, Saratoga, CA) and incubated 
overnight at 4 "C. The plate was washed with PBS- 
Tween and incubated for 1 hour each with 50 pL of the 
following PBS-Tween diluted reagents and subse- 
quent washings: deer serum (1 :500), biotinylated 
rabbit antideer immunoglobulin G (IgG) (1 :250), or 
alkaline-phosphatase avidin (Zymed Laboratories, 
San Francisco, CA) (1 : I  ,000). Finally, 50 pL substrate 
solution of 1 mg p-nitrophenyl phosphate per mL 
(Sigma Chemical Co., St. Louis, MO) in 10-percent 
diethanolamine buffer (pH 9.8) was distributed to each 
well. After incubation of approximately 20 minutes, 
the plate was scanned for absorbance at 405 nm 
using an MR 580 Microelisa Auto Reader (Dynatech 
Laboratories, Alexandria, VA). The rabbit antideer IgG 
(Kirkegaard & Perry Laboratories, Gaithersburg, MD) 
listed above was biotinylated according to the method 
described by Bayer et al. (1986) and Gretch et al. 
(1987). 
The experimental sera were tested in duplicate, 
and their results were expressed as percentage of the 
positive reference serum, which consisted of a pool of 
sera that had demonstrated anti-PZP antibody titers in 
the high positive range. Maximal serum antibody titers 
usually occur 4-6 weeks after initial PZP injection (Liu 
et al. 1989). We therefore determined the average 
value of maximal titers (designated as 100 percent) 
achieved during this period in six successfully 
contracepted does. All other titers are reported as a 
percentage of this positive reference serum. Pooled 
pre-immunization sera served as negative control. 
In the three-injection experiment, four PZP- 
treated does were blood-sampled for titer testing at 0, 
6, and 36 weeks. Samples were also taken from three 
of these does at 92 weeks (approximately 1 year after 
a booster inoculation). In the two-injection experi- 
ment, four PZP-treated and two sham-treated does 
were bled at 0, 6, and 40 weeks. Two of the above 
PZP-treated does were also bled at 52 and 64 weeks. 
In the single-injection, osmotic-pump experiment, 
blood samples were taken at 0, 4, 12, and 32 weeks 
after vaccination from PZP-injected does in the PZP- 
lmmunocontraception in White-Tailed Dee1 
pump group (n=3) and in the saline-pump group (n=2) 
for anti-PZP antibody testing. Untreated and 
unimplanted does were not bled. In the second 
single-injection experiment, employing controlled- 
release microspheres, blood samples were taken at 0, 
4, and 36 weeks after vaccination from four PZP- 
treated does. 
Where appropriate, titer data are presented as 
1 +the standard error of the means (S.E.M.). Results 
are presented descriptively, without statistical analysis, 
because responses to treatment were marked and 
straightforward in most cases, and differences in 
sample intervals and the small group sizes limited 
possibilities for comparisons. 
Results 
General 
None of the does exhibited a visibly draining abscess 
at the injection site, but a raised area of 16-24 mm in 
diameter developed at the final injection site on six 
does. This response disappeared after 8-10 days in 
three of the does, after 2 months in two other does, 
and after 6 months in the sixth doe. We observed 
60 percent of the does being bred. Subjectively, we 
observed no differences in breeding behavior between 
treated and control does. During the breeding sea- 
sons monitored in these studies, none of the control 
does was observed breeding after January, while 
26 percent of the PZP-treated does were observed 
breeding through February. Breeding of two treated 
does was observed during the first week of March. 
Parturition began late in May each year and 
spanned a 4-week period, with the exception of two 
fawn births in July and one in August of 1992. All 
fawns appeared healthy and nursed normally. 
Based on criteria described in Methods, does 
generally appeared to be in good health and physical 
condition throughout the study period from October 
1989 to July 1993. However, during this period two 
treated and two control does died from causes unre- 
lated to the study as determined by necropsy and 
bacterial culture. Deaths were associated with a jaw 
infection (n=l), a compound fracture (n=l), and 
Closfridiurn sp. (n=2). One treated and one control 
doe also died of undetermined causes within a 2-week 
period. 
Effects of Porcine Zonae Pellucidae on Fawn 
Production-Across all experiments, involving 
49 control-doe (no PZP) breeding seasons, 1 sham- 
treated doe and 2 untreated control does did not 
produce fawns. The fawning rate for sham (7 of 8) 
and untreated (39 of 41) control-doe breeding seasons 
was not different (p <0.01), and these control data 
were pooled. In contrast, the incidence of fawn 
production for the first breeding season was 0 percent 
(1 00-percent contraception) among does given 
multiple injections and 20 percent (80-percent contra- 
ception) among does given a single injection of 
porcine zonae pellucidae plus additional pellucidae in 
a controlled-release form of PZP vaccine. The annual 
incidence of fawning among control does ranged from 
83 to 100 percent between 1990 and 1993, and the 
incidence of twinning was 38 percent. Over all years, 
46 or 49 doe-breeding periods associated with control 
does resulted in production of fawns (reproduction 
success = 93.8 percent). Thus, the pooled pregnancy 
failure rate among control does was 6.2 percent. 
The fawn-production data for all treatments are 
presented in table 1. Among does given a three- 
injection protocol (in October-November 1989), none 
of five PZP-treated does produced fawns in 1990 
while all six control does did. After booster PZP 
treatment in October-November 1990, none of the 
above five PZP-treated does produced fawns in 1991. 
Of the above six control does, four received sham 
injections and two remained untreated in 1990; all six 
again produced fawns in 1991. One PZP-treated and 
one control doe in these groups died in 1991. In both 
1990 and 1991, the differences in fawn production 
between PZP-treated and control groups were signifi- 
cant (p <0.01). The remaining PZP-treated (n=4) and 
control (n=5) does were bred in the 1991 rut without 
further manipulation and produced fawns in 1992 as 
follows: four of five controls and three of four PZP- 
treated does. There was no difference between 
groups (p >0.1). 
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Table 1. Fawn production among white-tailed deer given three, two, or one injections with porcine zonae pellucidae 
Exoerimenl 
Percent of does 
producing fawns' 
Sample slze (n) 
Treatment Years slnce Placebo 
Year (+ or -) treatment PZP Control2 Placebo2 PZP 8 control3 
' Fawn production was determined by observation during May-August the year 
folowng PZP treatment. 
Control = untreated control; placebo = saline and adjuvant. 
Placebo and control does were pooled for comparisons wlth PZP~treated 
does because fawn production did not differ between placebo and control does 
(binomal test for equality of proponions, p c 0.05). 
- 
'Treatment was a singleinjection booster of PZP + adjuvant 
PZP = PZP injecton + PZP pump, placebo = PZP injecton +saline pump 
[ n=  2) or no pump (n= 1). 
Different from pooled control, based on binomla1 test tor equality of 
proponions, p <  0.05. 
Among does in the two-injection experiment that 
were bred in the 1990 rut, none of eight PZP-treated 
and eight of eight controls became pregnant. The 
between-group difference was significant (p  <0.01). 
One treated and one control doe from these groups 
died late in March. Necropsy showed that the PZP- 
treated doe was not pregnant but the control doe was. 
In order to test possible multiple-year effectiveness of 
porcine zonae pellucidae, without further treatment, all 
14 of the above does were bred in the 1991 rut. Two 
of seven previously treated with porcine zonae pellu- 
cidae and seven of seven control does produced 
fawns in 1992. The between-group difference was 
significant (p <0.05). All control animals had fawned 
by June 25, while the two births to PZP-treated does 
were June 29 and August 15. Prior to the 1992 rut, 
three of seven previously PZP-treated (two-injection) 
and three of seven control does were dropped from 
the study for economic reasons. The remaining four 
Data from the multiple-injection studies in table 1 
address reversibility of PZP treatment. Of the treated 
does monitored for reversibility, 75 percent produced 
fawns within 2 years of cessation of treatment. 
In the single-injection, osmotic-pump experiment, 
none of the does given a PZP injection produced 
fawns, regardless of the presence or absence of a 
pump or of PZP in the pump. Five of six untreated 
control does produced fawns. Statistical analysis was 
precluded by the small number of does in the respec- 
tive PZP treatment groups. 
In the single-injection, microsphere experiment, 
two of seven PZP-treated does and six of seven 
untreated control does produced fawns. The differ- 
ence between groups was significant (p <0.05). All 
control does fawned by June 30 except the one that 
fawned on July 8. Fawning dates for the two PZP- 
treated does were June 17 and July 14. 
PZP-treated does, which had not produced fawns Effects of Porcine Zonae Pellucidae o n  Antibody 
since the study had begun, were bred in the 1992 rut Titers-Blood samples obtained from PZP-treated 
and three of these four does produced fawns before does in all cases showed anti-PZP antibody titers in 
June 30, 1993. The other doe did not produce a fawn. baseline (prevaccination) which were <8 percent of 
All four of the remaining controls produced fawns. The the positive reference serum value, i.e., similar to 
difference between groups was not significant (p>0.10). titers found in negative reference serum. All of these 
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Table 2. Anti-PZP antibody titers during one breeding season in captive white-tailed does given 
PZP contraceptive vaccine' 
Anti-PZP antibody titers 
(% of positive reference s e r ~ m ) ~  
Postbreeding season4 Prebreeding season 
Prevaccination (weeks 32-40) (weeks 4-6) 
No. of does baseline5 ~.  ~- 
- - 
Experiment titer-tested (week 0) X SE X SE 
Control3 2 c8 c.3 <8 
Does were treated in October-November: fawning occurred the foilowing All values were below the lower Ilmt of detection. 
summer. No differences between pre- and postbreeding season tlters n any 
Positive reference serum, desgnated as 100%. was the average value of treatment group, based on analysis of variance with repeated measures. 
maximal titers achieved n SIX PZP-treated does that did not produce fawns. p c 0.05. 
Placebo~treated does from 2~injection experiment. 
PZP-treated does exhibited titers >33 percent of the 
positive reference serum value after vaccination. No 
does with titers >50 percent at the onset of a given 
breeding season produced fawns in the following 
summer. 
Specific antibody titer data are presented in table 
2. in the three-injection experiment, average titers 
among the four tested does were 102.1 ? 1.2 percent 
by 6 weeks after the initial inoculation and were 
72.7 + 15.7 percent at 36 weeks. In the two-injection 
experiment, anti-PZP antibody titers in four treated 
does averaged 100.0 + 0.0 percent of positive refer- 
ence serum 6 weeks after vaccination; and 40 weeks 
after PZP vaccination, titers in these same does 
averaged 92.0 + 5.2 percent. 
Additional blood samples taken from two of these 
does showed titers of 70 percent and 57 percent at 
52 weeks (prior to placement with a buck), and titers 
of 86 Dercent and 75 Dercent at 64 weeks. Neither of 
In the first single-injection study, prevaccination 
anti-PZP antibody titers were <8 percent of the 
positive reference serum titers. Titers in the PZP- 
pump group (n=3) averaged 76.3 f 7.2 percent, 
78.3 + 9.3 percent, and 69.5 + 11.8 percent at 4, 12, 
and 32 weeks, respectively. Titers in active (single 
PZP injection and saline pump) control does (n=2) 
averaged 41.5 + 1.5 percent, 50.0 i 5.5 percent, and 
41.5 i 12.5 percent at the above sampling times. 
In the second single-injection study, employing 
controlled-release microspheres, average anti-PZP 
titers in the four treated does sampled were 53.7 2 15.5 
percent at 4 weeks and 19.1 f 4.3% at 36 weeks. 
Anti-PZP antibody titers in the two PZP-treated does 
that produced fawns in this experiment were 32 percent 
and 27 percent at 4 weeks, i.e., prior to breeding. 
Discussion 
these does fawned. One doe that did produce a fawn 
had shown a 79-percent anti-PZP antibody titer In the present study, 100 percent of the does given 
weeks prior to breeding, but there were no N ~ ~ ~ ~ .  multiple injections of porcine zonae pellucidae and 
ber or February antibody data for this doe. Titers were percent Of given pellucidae as a single 
<8 percent at all times in samples from the two sham. injection with additional pellucidae provided in a 
treated does. controlled-release form were effectively contracepted 
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for the first breeding season after treatment. In 
contrast, does in combined sham and untreated 
control groups had only a 6.2-percent average annual 
failure rate in producing fawns. In all cases in which it 
was applicable, statistical analysis of fawning data 
within studies showed that the proportion of does 
producing fawns was lower for PZP-treated does than 
for control does. These results confirm of our previous 
report on PZP contraception in white-tailed deer 
(Turner et al. 1992). 
The mechanism of action of the PZP vaccine 
appears to be inhibition of fertilization (Sacco et al. 
1984). Porcine zona pellucida is comprised of several 
glycoproteins, at least one of which, ZP3, functions as 
a receptor for sperm surface molecules (Florman and 
Wassarman 1985). In the PZP-treated mare, it 
appears that anti-PZP antibodies block sperm-binding 
sites on the ovum (Liu et al. 1989). 
This study associates the presence of highly 
elevated, sustained anti-PZP titers with infertility in 
deer. Some does were monitored for antibody titers 
across one complete breeding season (6-9 months). 
Average titers appear to have remained highly elevated 
(73-92 percent of maximal) during this period in the 
does given multiple PZP injections while average titers 
among single-injection does never approached 
maximal. These results indicate that a minimum of 
two separate treatments with porcine zonae pellucidae 
may be necessary to maximize anti-PZP antibody 
titers across one breeding season. 
In a previous study of porcine zonae pellucidae 
in the mare using similar dosages and protocol, the 
lowest pellucidae titer associated with contraception 
was 64 percent of the positive reference serum for 
mares. In the present study, 3 of 13 does sampled 
just before or during the breeding period had titers 
between 40 and 50 percent of positive reference 
serum for does. None of these three does produced 
fawns from that breeding season. On the other hand, 
five of six does with titers <33 percent at the onset of 
breeding produced fawns the following summer. 
Although the small number of samples and titer 
variability across the test animals preclude firm 
conclusions regarding the contraceptive threshold for 
anti-PZP titers in white-tailed deer, the present data 
suggest that the threshold may be in the range of 
33 to 50 percent. One doe that had a 79-percent titer 
12 weeks before breeding did produce a fawn the 
following June. Because this doe was not sampled 
immediately prior to the breeding season, it is possible 
that her titers were below 50 percent during breeding. 
In this regard, another doe sampled 12 weeks before 
breeding had a 93-percent titer at that time, and her 
titer was 57 percent in November. 
The fawning data (table 2) also indicate that a 
single injection containing unsequestered porcine 
zonae pellucidae plus controlled-release PZP 
microspheres was less effective in providing contra- 
ception for one breeding season than were two or 
three separate exposures to the pellucidae (100-percent 
effective). The fact that the contraceptive effect was 
less in single-injection protocols than in multiple- 
injection protocols may reflect that the controlled- 
release component was not equivalent to a second 
PZP injection. First, the release pattern of porcine 
zonae pellucidae was continuous in the controlled- 
release preparations rather than discrete as in the 
bolus release provided by a second injection. Second, 
the multiple-injection protocol included adjuvant in 
each injection, while in the single-injection protocol, 
there was no adjuvant in the controlled-release 
component. Nonetheless, the partial effectiveness of 
the single-injection PZP preparations encourages 
further consideration of controlled release of porcine 
zonae pellucidae for use in immunocontraception 
(Eldridge et al. 1989, Wang et al. 1991b). 
The potential value of controlled-release compo- 
nents is highlighted by the observation that anti-PZP 
antibody titers were numerically greater in does given 
a PZP injection plus an osmotic pump containing 
porcine zonae pellucidae than in does given a PZP 
injection plus an osmotic pump containing saline. 
However, the small number of does per group and the 
lack of fawn production in the saline-pump group 
make it impossible to draw conclusions regarding a 
possible role of controlled-release porcine zonae 
pellucidae in this experiment. 
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It appears that PZP-mediated infertility is revers- 
ible. Eight PZP-treated does in the multiple-injection 
experiments were monitored for up to 2 years after 
cessation of PZP treatment. Six of these does pro- 
duced fawns within this 2-year period. Serum anti- 
PZP antibody titer data, where available, were 
consistent with reversibility: none of the titer-tested 
does that fawned after cessation of PZP treatment 
showed anti-PZP antibody titers >30 percent at the 
onset of the breeding season during which they 
conceived. However, investigation of the possibility of 
long-term infertility after several consecutive years of 
PZP treatment appears warranted, based on data 
which have demonstrated this in horses (Kirkpatrick et 
al. 1992). 
None of the does given a single PZP booster 
injection prior to year-2 breeding produced fawns the 
following summer. While it may be that the booster 
maintained the infertility seen in year 2, it is also 
possible that the original vaccination effect would have 
lasted 2 years without the booster. The latter possibil- 
ity is in part supported by the results of the second 
experiment. Seven does given a two-injection vacci- 
nation in year 1 were not treated in year 2. No fawns 
were born in the first summer after the vaccination, 
and only two of these seven does fawned in the 
second summer after the vaccination, despite the 
absence of a booster treatment. In any case, these 
results preclude conclusions regarding the contracep- 
tive effectiveness of a single PZP booster injection. 
The maintenance of infertility across two con- 
secutive breeding seasons in five of seven does given 
the two-injection PZP protocol was an unexpected 
finding. However, the limited antibody titer data in 
these does corroborated the fawning data, with titers 
maintained above 70 percent for 12 to 15 months in 
both does that were titer-treated at these times. 
Interestingly, the same PZP preparation and dosage 
given to does in the present study was effective in the 
mare for 1 but not 2 years (Kirkpatrick et al. 1992). 
The fact that the dosage per kg of body weight was 
severalfold greater in the deer than in the horse may 
explain why the antibody titer elevations in the deer 
were sustained longer. Studies of other PZP prepara- 
tions in various species, using dosages as much as 
tenfold greater than those used in the horse have 
reported the occurrence of long-term infertility (Mahi- 
Brown et al. 1985, Skinner et al. 1984, Dunbar et al. 
1989). 
In a previous PZP study in white-tailed deer, we 
reported that some PZP-treated does continued to be 
bred for at least 4 weeks longer than control does. 
The extension of estrus was also observed in the 
present studies in some PZP-treated does, with the 
time between end of breeding in control does and 
treated does ranging from 3 to 5 weeks. More than 
90 percent of white-tailed fawns are born in May and 
June (Halls 1984). In the present studies of 53 does, 
3 fawns were born after June 30. A control doe 
fawned on July 8, and two PZP-treated does fawned, 
on July 14 and August 15, respectively. While these 
results do not clearly demonstrate that incomplete 
contraception causes fawns to be born late in the 
season, the subject of breeding-period extension due 
to contraception warrants further study for potential 
influence on deer bioenergetics and fawn survival. 
Studies in Wild Deer 
Based on the encouraging results obtained in the 
studies with captive deer, we began to address the 
issues of accessibility to deer and deliverability. 
Toward this end, we entered into three field studies. 
The first study addressed accessibility to wild, free- 
roaming deer and it was carried out at Pt. Pelee 
National Park in Ontario, Canada, in collaboration with 
D. Voigt (Ontario Ministry of National Resources) and 
G. Mouland and D. Rieve (Park employees). This 
preliminary study examined the accessibility of deer to 
within darting range. 
Point Pelee National Park is a small natural area 
(16 kmz, with only 30 percent dry land) located in the 
southwest corner of Ontario. It is isolated from other 
natural areas by urban development and an intense 
agricultural zone. In recent years, the park has been 
subject to white-tailed deer densities as high as 
38 deer/km2 of dry land. Two population reductions 
were carried out, in 1991 and 1993, to reduce and 
maintain the population density at about 7 deer/km2. 
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Before immunocontraception via injection can be 
considered, investigators must make sure they have 
sufficient access to free-ranging does at low popula- 
tion density. To determine this, we established bait 
stations using apples and whole-kernel corn within 5 m 
of active deer trails at clearings before and after the 
1993 population reduction. Prior to the population 
reduction (density = 12.5 deer/km2 dry land), 14 bait 
stations were established throughout the park. Within 
5 days, seven stations had daily deer activity. Over a 
period of 15 days, all bait stations were being used. 
Random observations showed 44 deer utilizing bait 
stations (23 does, 2 bucks, 13 deer of unknown sex, 
and 4 fawns). After the population reduction, bait 
stations were reestablished at five of the previous 
locations where deer were known to remain. Within 
5 days, all 5 stations had daily deer activity, and over a 
period of 18 days, 23 deer were sighted ( I  0 does, 
6 bucks, and 7 of unknown status). Dusk and dawn 
were the predominant times of sighting. Because we 
found that the use of blinds gave us darting access to 
deer within 15 m, we believed the scenario adequate 
to attempt remote delivery of immunocontraception. 
The results of this study suggest that wild deer at Pt. 
Pelee can effectively be baited into darting range. 
The Pt. Pelee deer are among the most wary 
and least visible of the numerous deer populations 
that we have observed on our invited visits to various 
parks during the 1990's. Our results at Pt. Pelee 
suggest that appropriately operated baiting programs 
can guarantee access to deer for vaccination in most 
parks. It is further encouraging that accessibility was 
only temporarily hindered by the occurrence of the 
cull. This is particularly important in light of the high 
probability that already excessive deer populations in 
many places would be culled before management by 
immunocontraception would be implemented. 
In an effort to further our understanding of the 
vagaries of field delivery of porcine zonae pellucidae 
to deer, and in order to examine potential social- 
behavioral aspects of PZP contraception (such as 
continued estrus cycling and late fawning), we under- 
took a second field study. In collaboration with W. 
McShea and S. Monfort, we remotely vaccinated free- 
roaming does with porcine zonae pellucidae at the 
Smithsonian Institution's Conservation and Research 
Center in Front Royal, VA. The Front Royal field site 
was a 30-ha fenced area of mixed wood (80 percent) 
and fields (20 percent). The study population con- 
sisted of 28 adult, ear-tagged does, 4 bucks, and an 
unknown number of fawns. 
The PZP vaccine treatment consisted of either 
two injections (3 weeks apart) of porcine zonae 
pellucidae plus Freund's adjuvant as described 
previously (n=10) or one injection of porcine zonae 
pellucidae plus Freund's adjuvant and a second dose 
of the pellucidae in controlled-release microspheres 
(n=9), as described previously. The nine remaining 
does, serving as controls, were injected with saline 
plus adjuvant. All injections were given in September. 
Access to the does was achieved by stalking, blinds, 
and bait stations. Most of the deer were extremely 
wary and nervous. Best success in darting was 
accomplished using blinds at bait stations. All does 
were vaccinated with a self-injecting 1 -cm3 dart fired 
from a 22-caliber rifle (Pneu-Dart, lnc., Williamsport, 
PA). Effectiveness of treatment was determined by 
counting fawns between June and August the follow- 
ing year. Does and bucks were also monitored for 
mating behavior and activity budgets between October 
and March. Details of behavioral and activity monitor- 
ing are presented in the paper by McShea et al. 
elsewhere in this book. Treatment effects on fertility, 
behavior, and activity budgets are presented below. 
Regarding efficacy, none of the 10 does receiv- 
ing 2 injections of porcine zonae pellucidae produced 
fawns; 67 percent of the one-injection does and 
89 percent of the untreated control does produced 
fawns. All except one of the fawns produced by the 
one-injection does were born between mid-July and 
the end of August. The results demonstrate complete 
effectiveness of the two-injection PZP treatment. They 
also suggest that the one-injection PZP treatment 
inhibited fertility for most of the breeding season but 
did not prevent conception at the end of the season. 
Based on titer data from our previous studies and the 
fawning dates in the present study, it is likely that the 
anti-PZP antibody titers fell below the contraceptive 
threshold by the March following treatment. 
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Regarding behavior and activity budgets, 38 hours 
of observation on females revealed that contracepted 
does were more active and spent less time feeding 
than control does. However, the average body weight 
of treated does was greater than that of control does 
at the end of the winter. These results suggest that for 
does, the metabolic drain of pregnancy is greater than 
the metabolic demands of an extended breeding 
season with greater activity. During 84 hours of 
observations on males, mating occurred until March, 
but mating activity shifted from largest to smallest 
males as the winter progressed. Also, the intensity of 
the rut fell markedly after December. These condi- 
tions considerably moderated the energetic cost to 
bucks of an extended breeding seasons associated 
with PZP contraception. While these results suggest 
that there are no life-threatening behavioral or ener- 
getic consequences to a breeding season extended by 
PZP contraception, the details of PZP effects on these 
factors nonetheless deserve further exploration. 
Remote Assessment of 
Reproductive Status 
As a corollary to the development of PZP 
immunocontraception for wildlife management, we 
have been exploring the remote assessment of 
reproductive status in free-roaming wildlife via moni- 
toring of sex-hormone metabolites in remotely col- 
lected urine and feces (Kirkpatrick et al. 1990b, 
1991 b, and 1992). Recently, we have begun to 
evaluate this technology for use in white-tailed deer. 
Using fecal samples collected from deer studied in the 
reports presented in this paper, we have performed a 
preliminary analysis of concentrations of pregnancy- 
specific steroid metabolites in pregnant and nonpreg- 
nant does. The metabolites, measured by specific 
ELISA, were estrone conjugates (E,C) and preg- 
nanediol-3a-glucuronide (PdG). In samples collected 
between April 25 and May 21 from does that produced 
fawns (n=9) and does that did not produce fawns, 
there was a 100-percent correlation between preg- 
nancy and elevated E,C, andlor elevated PdG. The 
E,C and PdG concentrations averaged l o x  and 4x 
greater, respectively, in pregnant does as compared to 
nonpregnant does. All does that produced fawns 
showed an E,C concentrations > I  .0 ng per g of feces, 
while all nonpregnant does had E,C levels <0.7 ngig. 
All but two does that fawned exhibited PdG >7 ng per 
g of feces, while only one doe that did not fawn had 
PdG >5 ngig. In general, E,C appears to be more 
reliable than PdG as an indicator of pregnancy, 
although it is useful to have both measures to maxi- 
mize the probability of accurate assessment. These 
results are generally similar to those reported for 
equids, and suggest that this methodology can be 
useful for remote assessment of reproductive status in 
wild white-tailed deer. 
Summary 
For all treatments in which does were exposed to 
porcine zonae pellucidae plus adjuvant at least twice 
within 4 weeks, the contraceptive effectiveness was 
100 percent. Our combined data for all one-injection 
protocols shows a 42.1-percent fertility rate. While 
this represents better than 50-percent reduction in 
fertility relative to controls, we consider the single- 
injection efforts to be a failure. Most of the fawns born 
to one-injection does were delivered in August. This 
late-fawning phenomenon, with the consequent 
probable high winter mortality of late-born fawns, 
makes it essential to complete the development of a 
single-injection vaccine with a guaranteed minimum of 
1-year efficacy. In fact, without denying the impor- 
tance of issues such as recombinant v. natural ZP and 
dart v. biobullet, it is clear that there can be no practi- 
cal field application of this technology without a single- 
injection vaccine that is highly effective for at least 
1 year. The bioengineering of this PZP preparation is 
under way. 
Regarding our continuation of field studies of wild 
deer populations, we completed the PZP vaccination 
of 68 wild, free-roaming does on Fire Island National 
Seashore in NewYork State in October 1993. The 
68 treated does represent >70 percent of the adult 
does in the discrete population that we targeted. We 
employed a two-injection protocol because the single- 
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injection, I -y r  vaccine was still in development. The 
results of this study should provide useful data toward 
the potential use of PZP immunocontraception for wild 
deer management in limited deer populations. 
Conclusions 
The studies presented in this paper have clearly 
demonstrated that PZP immunocontraception can 
prevent pregnancy in white-tailed deer. A brief reex- 
amination of the requirements for management-useful 
contraceptive in wild, free-roaming deer reveals that 
our data also show feasibility of access to the deer, 
remote delivery of PZP vaccine, and remote assess- 
ment of pregnancy. When development of a single- 
injection capability is completed, management of 
many urban deer populations with PZP immuno- 
contraception should be technologically realistic. In 
the meantime, other issues regarding immuno- 
contraception must be addressed in the area of public 
attitudes and education, administration and policies, 
and long-term management strategies (Kellert 1991), 
all of which are influenced by politics, economics, and 
management goals as discussed in other papers from 
this conference. 
Members of our research team have visited 
many locations where insular deer populations are 
presently so large that the deer have already severely 
compromised their habitat. Many species of plants 
and animals, not just deer, are now suffering the 
consequences of ballooning deer numbers. While 
contraception may be used to limit population growth, 
it will not reduce the numbers presently in excess. 
Therefore, initial population reductions by existing 
means may be necessary where indicated in order to 
protect habitat for the future and to establish a basal 
population of deer that thenceforth may be managed 
by contraception. 
While our research team recognizes that wildlife 
population control is an important issue, the need for 
such control reflects a much larger and burning issue: 
expanding human population. We believe that as we 
continue our work, all of us in the growing field of 
wildlife contraception have an obligation to help focus 
public consciousness in this regard. 
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